BACKGROUND: In December 2014, a new kidney allocation system (KAS) was implemented nationwide with the goal of improving longevity matching, increasing access to sensitized patients, and improving racial/ethnic disparities. STUDY DESIGN: National cohort study of US kidney transplantation programs, analyzing hospital-level outcomes (October 2012 to June 2016) using University HealthSystem Consortium data. In-hospital outcomes and costs were analyzed for trends over time using interrupted time series analysis with segmented regression. RESULTS: There were 38,016 kidney transplantation procedures analyzed during the 3.8-year period. Over time, there was a mean increase of 2.7 cases/month (95% CI -0.02 to 5.4; p = 0.059), unaffected by KAS (18.9 case increase; p = 0.5601). Implementation of KAS led to significant changes in patient demographics, including a decrease in age (-2.8 years; p < 0.001), increase in number of African Americans (3.8%; p < 0.001), decrease in number of Caucasians (6.0%; p < 0.001), increase in number of Hispanics (2.9%; p < 0.001), increase in congestive heart failure (1.3%; p < 0.001), and decrease in diabetes with complications (4.0%; p < 0.001). The KAS had no impact on length of stay (0.12 days; 95% CI -0.11 to 0.35), length of stay index (0.01; 95% CI -0.03 to 0.05), ICU cases, ICU length of stay, patient safety indicators, or in-hospital mortality. The KAS led to a significant increase in delayed graft function rates (5.4%; 95% CI 23.3% to 7.4%); total in-hospital costs ($2,429; 95% CI $594 to $4.263); and 7-day (2.2%), 14-day (2.6%), and 30-day (2.7%) readmission rates. CONCLUSIONS: Policy changes in organ allocation can have a significant impact on perioperative costs and outcomes, which can have a downstream influence on transplantation center perisurgical care processes.
BACKGROUND: In December 2014, a new kidney allocation system (KAS) was implemented nationwide with the goal of improving longevity matching, increasing access to sensitized patients, and improving racial/ethnic disparities. STUDY DESIGN: National cohort study of US kidney transplantation programs, analyzing hospital-level outcomes (October 2012 to June 2016) using University HealthSystem Consortium data. In-hospital outcomes and costs were analyzed for trends over time using interrupted time series analysis with segmented regression. RESULTS: There were 38,016 kidney transplantation procedures analyzed during the 3.8-year period. Over time, there was a mean increase of 2.7 cases/month (95% CI -0.02 to 5.4; p = 0.059), unaffected by KAS (18.9 case increase; p = 0.5601). Implementation of KAS led to significant changes in patient demographics, including a decrease in age (-2.8 years; p < 0.001), increase in number of African Americans (3.8%; p < 0.001), decrease in number of Caucasians (6.0%; p < 0.001), increase in number of Hispanics (2.9%; p < 0.001), increase in congestive heart failure (1.3%; p < 0.001), and decrease in diabetes with complications (4.0%; p < 0.001). The KAS had no impact on length of stay (0.12 days; 95% CI -0.11 to 0.35), length of stay index (0.01; 95% CI -0.03 to 0.05), ICU cases, ICU length of stay, patient safety indicators, or in-hospital mortality. The KAS led to a significant increase in delayed graft function rates (5.4%; 95% CI 23.3% to 7.4%); total in-hospital costs ($2,429; 95% CI $594 to $4.263); and 7-day (2.2%), 14-day (2.6%), and 30-day (2.7%) readmission rates. CONCLUSIONS: Policy changes in organ allocation can have a significant impact on perioperative costs and outcomes, which can have a downstream influence on transplantation center perisurgical care processes.
Authors: Peter P Reese; Roy D Bloom; Justine Shults; Arwin Thomasson; Adam Mussell; Sylvia E Rosas; Kirsten L Johansen; Peter Abt; Matthew Levine; Arthur Caplan; Harold I Feldman; Jason Karlawish Journal: Transplantation Date: 2014-01-27 Impact factor: 4.939
Authors: David J Taber; Nicole A Pilch; John W McGillicuddy; Charles F Bratton; Kenneth D Chavin; Prabhakar K Baliga Journal: Am J Med Qual Date: 2012-07-22 Impact factor: 1.852
Authors: Mark D Stegall; Peter G Stock; Kenneth Andreoni; John J Friedewald; Alan B Leichtman Journal: Hum Immunol Date: 2016-08-21 Impact factor: 2.850
Authors: Sri G Yarlagadda; Steven G Coca; Richard N Formica; Emilio D Poggio; Chirag R Parikh Journal: Nephrol Dial Transplant Date: 2008-12-22 Impact factor: 5.992
Authors: Ulrich Pein; Matthias Girndt; Silke Markau; Annekathrin Fritz; Alberto Breda; Michael Stöckle; Nasreldin Mohammed; Felix Kawan; Andre Schumann; Paolo Fornara; Karl Weigand Journal: World J Urol Date: 2019-05-24 Impact factor: 4.226
Authors: Kyle R Jackson; Courtenay Holscher; Jennifer D Motter; Niraj Desai; Allan B Massie; Jacqueline Garonzik-Wang; Nada Alachkar; Dorry L Segev Journal: Transplantation Date: 2020-07 Impact factor: 5.385
Authors: Sameera Senanayake; Nicholas Graves; Helen Healy; Keshwar Baboolal; Adrian Barnett; Matthew P Sypek; Sanjeewa Kularatna Journal: BMC Health Serv Res Date: 2020-10-09 Impact factor: 2.655
Authors: Christine Park; Mandisa-Maia Jones; Samantha Kaplan; Felicitas L Koller; Julius M Wilder; L Ebony Boulware; Lisa M McElroy Journal: Int J Equity Health Date: 2022-02-12
Authors: Hanadi Y Hamadi; Hani M Wadei; Jing Xu; Dayana Martinez; Aaron Spaulding; Shehzad K Niazi; Tambi Jarmi Journal: J Clin Med Res Date: 2022-03-25